title: Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
authors.affiliation: University of Texas Southwestern, Dallas, TX, USA.
authors.forename: Harris V
authors.initials: HV
authors.lastname: Naina
authors.forename: Daniel
authors.initials: D
authors.lastname: Levitt
authors.forename: Madhuri
authors.initials: M
authors.lastname: Vusirikala
authors.forename: Larry D
authors.initials: LD
authors.lastname: Anderson
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Scaglioni
authors.forename: Angela
authors.initials: A
authors.lastname: Kirk
authors.forename: Robert H
authors.initials: RH
authors.lastname: Collins
mesh_terms: D000328:Adult; D000617:Aminoglycosides / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D000079982:Gemtuzumab; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000601:surgery; D017254:Leukemic Infiltration / Q000188:drug therapy / Q000473:pathology; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D010087:Oxides / Q000008:administration & dosage; D011877:Radionuclide Imaging; D012074:Remission Induction; D016879:Salvage Therapy; D023981:Sarcoma, Myeloid / Q000000981:diagnostic imaging / Q000188:drug therapy; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage / Q000627:therapeutic use*; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001152:Arsenicals; D001565:Benzoates; D010087:Oxides; D013764:Tetrahydronaphthalenes; C061133:tamibarotene; D014212:Tretinoin; D004317:Doxorubicin; D000079982:Gemtuzumab; D015122:Mercaptopurine; D000077237:Arsenic Trioxide; D008727:Methotrexate; D015255:Idarubicin